PhaseBio Pharmaceuticals Inc
F:2K4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PhaseBio Pharmaceuticals Inc
F:2K4
|
US |
|
E
|
ECOVE Environment Corp
TPEX:6803
|
TW |
|
G
|
Goodness Growth Holdings Inc
CNSX:GDNS
|
US |
|
GOME Retail Holdings Ltd
OTC:GMELF
|
CN |
|
C
|
Copper Property CTL Pass Through Trust
OTC:CPPTL
|
US |
|
Batero Gold Corp
XTSX:BAT
|
CA |
|
C
|
China Education Resources Inc
XTSX:CHN
|
CA |
|
B
|
Blue Prism Group PLC
F:B11
|
UK |
|
Q
|
Qualitas Controladora SAB de CV
BMV:Q
|
MX |
|
Candelaria Mining Corp
XTSX:CAND
|
CA |
|
I
|
Insight Business Support PLC
LSE:IBSU
|
UK |
|
I
|
Intellipharmaceutics International Inc
OTC:IPCIF
|
CA |
|
Pharmadrug Inc
OTC:LMLLF
|
CA |
|
Equity Metals Corp
XTSX:EQTY
|
CA |
|
S
|
Sondrel (Holdings) PLC
F:D0Q
|
UK |
|
Argonaut Resources NL
ASX:ORP
|
AU |
|
C
|
Centerra Gold Inc
XBER:GOU
|
CA |
|
E
|
Essex Minerals Inc
XTSX:ESX
|
CA |
|
G
|
Glorious Property Holdings Ltd
F:GI0A
|
HK |
Bankruptcy Probability
PhaseBio Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PhaseBio Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
|
49.9 USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
440.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PhaseBio Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PhaseBio Pharmaceuticals Inc has total debt of 1.4m USD. This includes both short-term (0 USD) and long-term (1.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
